| 2019 | Geistlich welcomes his 11th daughter: the expanded presence in Asia leads to the foundation of Geistlich Pharma Japan K.K. |
| 2016 | Geistlich Pharma India Pvt. Ltd., based in New Delhi, is a member of the Swiss parent company. |
| 2014 | Geistlich Pharma Australia Pty Ltd. has been established in Sydney. |
| 2012 | The eighth affiliate Geistlich Pharma North America starts operations and is marketing biomaterials for bone regeneration in the USA and Canada. |
| 2011 | Geistlich Pharma expands its presence in Asia by setting up an affiliate in South Korea in addition to the affiliate set up in China in 2008. |
| 2010 | Geistlich Pharma sets up the affiliate Geistlich Pharma do Brasil based in Sao Paolo. In future Geistlich biomaterials will be available directly on the largest South American market. |
| 2008 | Foundation of the French affiliate Geistlich Pharma France SA. in Roissy-en-France near Paris. The Geistlich Pharma Representative office in Peking becomes the Chinese affiliate Geistlich Trading (Beijing) Co., Ltd. |
| 2006 | The industrial bone processing is discontinued. |
| 2005 | The Geistlich Pharma Representative Office is established in Peking with the objective to provide scientific support to the regenerative medicine and to further promote our technologies and products in China. |
| 2003 | The subsidiary Geistlich Biomaterials Italia is founded in Thiene, Italy. |
| 2002 | Production of gelatine is given up. The collagen foil activities are sold in 2005. |
| 1999 | The Geistlich company is converted into a holding company. The operational activities are assembled in newly formed subsidaries: Geistlich Pharma AG (biomaterials, pharmaceuticals), Geistlich Ligamenta AG (adhesives), Geistlich Alimenta AG (collagen foils), Geistlich Agrasana AG (fats and fertilizers), and Geistlich Immobilia AG (real estate). |
| 1996 | Foundation of the German subsidiary Geistlich Biomaterials Vertriebsgesellschaft mbH in Baden-Baden |
| 1995 | The Geistlich company incorporates a quality system, that is certified according to ISO 9001:2000.Geistlich Pharma is additionally certified according to ISO 13485:2003, RL 93/42 EWG and CMDCAS and has implemented the requirements of 21 CFR Part 820. |
| 1986 | Geistlich Bio-Oss® is the first natural bone substitution material produced by the Biomaterials Division. Other biomaterials are realised outgoing by this innovation for the dental medicine and orthopedics. |
| 1960 | The subsidiary, Geistlich Sons Ltd. in Chester, Great Britain is founded. Since then, further collaborations have continued to be made throughout the world. |
| 1951 | Acquisition of the majority of the shares of Delta Zofingen AG |
| 1950 | GEWO GmbH subsidiary is founded in Baden-Baden, Germany. |
| 1909 | the sons of Eduard Geistlich transform the company into a shareholder company. The company developed further and took up production of pharmaceutical products in 1943. |
| 1869 | more space was needed so the company moved to Schlieren. Here the company started it's considerable growth. In 1899 Eduard Geistlich, Heinrich's son, acquired a factory in Wolhusen/ Lucerne which was developed to facilitate their growing activities. |
| 1851 | The "glue factory" was founded in Zurich by Heinrich Geistlich. |
